Referring to today’s press release from EpiCept Corporation (under name change to Immune Pharmaceuticals Inc), the company will carry out a reverse stock split, 1:40. The shares will be traded under new ISIN code with effect from August 21, 2013. In connection to the change of ISIN code, the company will also change short name, as a result of the merger with Immune Pharmaceuticals Ltd.
| Current short name: | EPCT |
| Terms: | Reverse stock split 1:40 |
| Current ISIN: | US2942643048 |
| Last day of trading with current ISIN code: | August 20, 2013 |
| New ISIN code: | US45254C1018 |
| New short name: | IMNP |
| First day of trading with new short name and new ISIN code: | August 21, 2013 |
| Unchanged orderbook ID: | 32838 |
For further information about the reverse stock split, please contact EpiCept Corporation. For further information about this exchange notice please contact Andreas Jensen or Eva Norling, telephone +46 8 405 60 00, or iss@nasdaqomx.com